Purpose This study developed machine learning models to predict in-hospital mortality,
initiation of acute renal replacement therapy, and mechanical ventilation in patients with …

Background: Despite recommendations from clinical practice guidelines to initiate and titrate
guideline-directed medical therapy (GDMT) during their hospitalization, patients with acute …

We clarified the association between changes in the number of foundational medications for
heart failure (FMHF) during hospitalization for worsening heart failure (HF) and post …

2022 American Heart Association/American College of Cardiology/Heart Failure Society of
America heart failure (HF) clinical practice guidelines offer class of recommendation I for use …

Background Methamphetamines are a common cause of systolic heart failure (HF). There
are limited data on the prognosis associated with hospitalizations for decompensated HF in …

Objectives To determine the impact of risk stratification using the MEESSI-AHF (Multiple
Estimation of risk based on the Emergency department Spanish Score In patients with acute …

Background Digoxin was one of the first agents used in the management of heart failure with
reduced ejection fraction (HFrEF). Concerns over its safety, efficacy, and the introduction of …

Methods Study design. This study was conducted using three Japanese prospective hospital-
based registries for acute HF, ie, NARA-HF, WET-HF, and REALITY-AHF. All study …

Diabetes mellitus (DM) is a well-established risk factor for adverse prognosis in patients with
heart failure (HF). Outcomes in this patient population have not been thoroughly investigated …

Beta-blockers are essential drugs for the treatment of Chronic Heart Failure (HF), and their
use for heart rate (HR) control in acute HF was not properly standardized due to the …